Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Kostkiewicz

Showing results (91-100 of 93) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 93 results.
Cardiology Journal|September 14, 2018
Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trialTomasz Jadczyk, Joanna Ciosek, Aleksandra Michalewska-Wludarczyk, et al.
Circulation Research|December 2, 2016
Effects of Transendocardial Delivery of Bone Marrow-Derived CD133<sup>+</sup> Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL TrialWojciech Wojakowski, Tomasz Jadczyk, Aleksandra Michalewska-Włudarczyk, et al.
Kardiologia Polska|January 2, 2025
Diagnosis and treatment of Fabry disease. Expert Opinion of the Polish Cardiac Society and the Polish Forum for Fabry DiseasePiotr Podolec, Przemysław Mitkowski, Agnieszka Słowik, et al.
Pageof 10

Showing results (91-100 of 93) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 93 results.
Cardiology Journal|September 14, 2018
Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trialTomasz Jadczyk, Joanna Ciosek, Aleksandra Michalewska-Wludarczyk, et al.
Circulation Research|December 2, 2016
Effects of Transendocardial Delivery of Bone Marrow-Derived CD133<sup>+</sup> Cells on Left Ventricle Perfusion and Function in Patients With Refractory Angina: Final Results of Randomized, Double-Blinded, Placebo-Controlled REGENT-VSEL TrialWojciech Wojakowski, Tomasz Jadczyk, Aleksandra Michalewska-Włudarczyk, et al.
Kardiologia Polska|January 2, 2025
Diagnosis and treatment of Fabry disease. Expert Opinion of the Polish Cardiac Society and the Polish Forum for Fabry DiseasePiotr Podolec, Przemysław Mitkowski, Agnieszka Słowik, et al.
Pageof 10